ChromoGenics delivers I-Window glass to a restaurant in Stockholm for an order value of SEK 250 thousand

ChromoGenics AB (publ) supplies I-Window glass to one of Sweden’s largest real estate companies with business in the Stockholm region for a retro-fit project where existing windows are upgraded with energy-efficient I-Window glass.

The project is a repeat order for a retro-fit project of approximately 50 sqm I-Window glass including construction work with planned completion in the fourth quarter of 2018.

The property owner has chosen to upgrade the property’s windows to energy-efficient I-Window glass and this is an additional order where windows in the street level are upgraded to I-Window. A restaurant resides and runs its operations in the premises.

“ChromoGenics I-Window glass contains a static solar control that is very energy efficient. Satisfied tenants and lower maintenance costs are important for all property owners. We are pleased that customers choose to return for further installation of our products,” says Jerker Lundgren, CEO of ChromoGenics.

Contact:

Jerker Lundgren, CEO
Susanne Andersson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
E-mail: info@chromogenics.com
Certified Adviser: G&W Fondkommission

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.


About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.

ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. http://www.chromogenics.com 

Download as PDF

Subscribe

Subscribe to our news